Cyclin-D1 expression in node-positive (N+) and node-negative (N-) infiltrating human mammary carcinomas

Area of Science:

• Oncology
• Molecular Biology
• Cell Cycle Regulation

Background:

• Cyclin-D1 (CD1) is a key regulator of the cell cycle.
• CD1 expression patterns in human mammary carcinomas require further elucidation.
• Estrogen's role in CD1 induction in steroid-responsive tissues is recognized.

Purpose of the Study:

• To analyze Cyclin-D1 (CD1) expression in human mammary carcinomas.
• To investigate the relationship between CD1 expression and tumor characteristics such as nodal status and estrogen receptor (ER) status.
• To explore the correlation between CD1 expression, DNA synthesis, and aneuploidy.

Main Methods:

• Immunohistochemistry (IHC) and flow cytometry (FCM) were employed to assess CD1 expression.
• Analysis included correlation with nodal status (N- vs. N+), ER status, and H3-thymidine labelling index (H3Td-LI).
• DNA content analysis was combined with CD1 expression assessment.

Main Results:

• 52.5% (IHC) and 50% (FCM) of tumors showed strong CD1 expression.
• Higher CD1 expression was observed in node-negative, ER-positive tumors.
• CD1 expression correlated with high DNA synthesis (H3Td-LI) in node-positive tumors.
• 70% of aneuploid tumors (19/27) exhibited strong CD1 expression.

Conclusions:

• CD1 expression is frequent in mammary carcinomas and shows varied associations with tumor characteristics.
• A link between CD1, DNA synthesis, and aneuploidy in breast cancer warrants further investigation.
• CD1 over-expression might play a role in the development of aneuploidy in mammary carcinomas.